Richard Henson is the CEO of PhageTech, LLC. He is a medical device executive with over 30 years of experience in diagnostic medical device development and manufacturing. He currently serves on the boards of Halo Healthcare, a breast cancer diagnostic company and ResVeRx, Inc., a nutraceutical company. He is also a board member of OCTANe and a member of the Chancellors CEO Roundtable at UC Irvine. An experienced CEO with public and private companies, Richard has worked with many high-tech firms in biomedical, consumer and critical power industries. He has worked for several Fortune 500 firms and spent several years working in Europe. He has also served as President of Clary Corporation, a public company that manufactures harsh environment power systems for medical, military and transportation applications. He has a strong combination of product development, technical, sales, marketing and managerial experience.